Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS)
CNY 88.82
(-1.03%)
CNY 88.82
(-1.03%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 669.36 Million CNY | 36.29% |
| 2022 | 491.14 Million CNY | 34.55% |
| 2021 | 365.02 Million CNY | 59.32% |
| 2020 | 229.11 Million CNY | 36.98% |
| 2019 | 167.25 Million CNY | 61.89% |
| 2018 | 103.31 Million CNY | 83.86% |
| 2017 | 56.19 Million CNY | 80.45% |
| 2016 | 31.14 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 220.83 Million CNY | 34.74% |
| 2024 Q2 | 238.41 Million CNY | 7.96% |
| 2023 Q1 | 157.82 Million CNY | 38.17% |
| 2023 FY | 669.36 Million CNY | 36.29% |
| 2023 Q4 | 163.9 Million CNY | -20.53% |
| 2023 Q3 | 206.23 Million CNY | 14.27% |
| 2023 Q2 | 180.47 Million CNY | 14.36% |
| 2022 FY | 491.14 Million CNY | 34.55% |
| 2022 Q4 | 114.22 Million CNY | -20.81% |
| 2022 Q3 | 144.24 Million CNY | 19.29% |
| 2022 Q2 | 120.91 Million CNY | 8.2% |
| 2022 Q1 | 111.75 Million CNY | 21.25% |
| 2021 Q1 | 70.13 Million CNY | -6.75% |
| 2021 Q3 | 99.98 Million CNY | -2.68% |
| 2021 Q2 | 102.74 Million CNY | 46.5% |
| 2021 Q4 | 92.16 Million CNY | -7.82% |
| 2021 FY | 365.02 Million CNY | 59.32% |
| 2020 Q3 | 65.36 Million CNY | -1.3% |
| 2020 Q1 | 22.31 Million CNY | -18.32% |
| 2020 FY | 229.11 Million CNY | 36.98% |
| 2020 Q4 | 75.21 Million CNY | 15.06% |
| 2020 Q2 | 66.22 Million CNY | 196.77% |
| 2019 Q4 | 27.31 Million CNY | -28.94% |
| 2019 FY | 167.25 Million CNY | 61.89% |
| 2019 Q3 | 38.44 Million CNY | -13.79% |
| 2019 Q2 | 44.59 Million CNY | 20.62% |
| 2019 Q1 | 36.96 Million CNY | 159.45% |
| 2018 Q4 | 14.24 Million CNY | 0.0% |
| 2018 FY | 103.31 Million CNY | 83.86% |
| 2017 FY | 56.19 Million CNY | 80.45% |
| 2016 FY | 31.14 Million CNY | 0.0% |